Sales from the company’s medical device business increased 6.4 percent in the second quarter, reaching a total of $1.37 billion. Net sales rose by 3.2 percent to $5.33 billion, surpassing Wall Street’s prediction of $5.24 billion.
Abbott’s medical device division produces products for heart, diabetes and eye patients.
Recently, Abbott shared a definitive agreement to acquire St. Paul, Minn.-based device company St. Jude Medical for $25 billion. The deal is expected to close by the end of the year.
More articles on medical devices:
This headband isn’t for fashion— it offers migraine relief
Zimmer Biomet acquires Medtech SA
FDA approves Syneron Candela’s weight loss device
